Silvercrest Asset Management Group »

Avita Therapeutics shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.9M 242k 16.03
2020-09-30 $2.6M 102k 25.16

More positions owned by Silvercrest Asset Management Group

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Matador Resources (MTDR)
Oracle Corporation (ORCL)
Alphabet Inc Class C cs (GOOG)
Cadence Bank (CADE)
Ameriprise Financial (AMP)
Home Depot (HD)
Abbott Laboratories (ABT)
Apple (AAPL)
Carlisle Companies (CSL)
Casella Waste Systems (CWST)
Element Solutions (ESI)
Microchip Technology (MCHP)
Ametek (AME)

View all positions for Silvercrest Asset Management Group

Top funds holding Avita Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
AWM Investment Company
Silvercrest Asset Management Group
Northern Trust
CenterBook Partners
Bank of New York Mellon
AQR Capital Management
Goldman Sachs Group
Globeflex Capital
Soleus Capital Management
1492 Capital Management
Nuveen Asset Management

View all funds holding Avita Therapeutics